Showing results (131-140 of 16,795) with videos related to
Sort By:
Pageof 1,680
British Journal of Haematology|January 15, 2011
A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemiaPeter Hillmen, Dena R Cohen, Kim Cocks, et al.British Journal of Haematology|January 8, 2011
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocolsRachael F Grace, Suzanne E Dahlberg, Donna Neuberg, et al.British Journal of Haematology|February 1, 2011
Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterationsUlrike Bacher, Torsten Haferlach, Tamara Alpermann, et al.British Journal of Haematology|February 1, 2011
The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trialWinfred Wang, Carlo Brugnara, Cathie Snyder, et al.British Journal of Haematology|January 13, 2011
The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controlsBrian T Hill, Lisa Rybicki, Brian J Bolwell, et al.British Journal of Haematology|January 12, 2011
Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patientsCarlos Besses, Alberto Alvarez-Larrán, Luz Martínez-Avilés, et al.British Journal of Haematology|February 10, 2011
Microparticles, malignancy and thrombosisSharon Zahra, Julia A M Anderson, David Stirling, et al.British Journal of Haematology|March 8, 2011
Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphomaCarlos Fernández de Larrea, Antonio Martínez-Pozo, Santiago Mercadal, et al.British Journal of Haematology|March 8, 2011
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)Anjali S Advani, Sarah Gibson, Elizabeth Douglas, et al.British Journal of Haematology|March 1, 2011
Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signalsAlison M McCaig, Emilio Cosimo, Michael T Leach, et al.Pageof 1,680